Target intelligence / Profile preview

Bacterial adhesins (PapG and FimH) (PapG/FimH)

Target
PapG/FimH
Molecular classification
Bacterial surface protein, Lectin, Adhesin
01

Overview

Bacterial adhesins, primarily PapG and FimH, are critical virulence factors located on the tips of fimbriae in uropathogenic Escherichia coli (UPEC) (Howell et al., 2005). These proteins function as lectins, enabling the bacteria to adhere to specific carbohydrate receptors on the surface of uroepithelial cells, which is the essential first step in the pathogenesis of urinary tract infections (UTIs) (Gupta et al., 2007). PapG, found on P-fimbriae, binds to alpha-Gal(1-4)-beta-Gal receptors, while FimH, found on Type 1 fimbriae, binds to mannose-containing receptors (Lavigne et al., 2008). Cranberry proanthocyanidins (PACs), particularly those with unique A-type linkages, exert their therapeutic effect by binding to these adhesins or causing conformational changes that prevent their interaction with host receptors (Foo et al., 2000). This anti-adhesion mechanism effectively inhibits bacterial colonization and biofilm formation without exerting the selective pressure that leads to antibiotic resistance (Ahuja et al., 1998). Consequently, cranberry-derived products are widely used as a prophylactic strategy to reduce the recurrence of UTIs by facilitating the clearance of pathogens through urine flow (Jepson et al., 2012). The efficacy of these compounds is often measured using the urinary anti-adhesion activity (AAA) bioassay, which correlates with the concentration of soluble PACs excreted in the urine (Howell et al., 2010). While generally safe, high consumption of cranberry products may pose risks such as kidney stones due to oxalate content or potential interactions with anticoagulant medications like warfarin.

Other names
P-fimbriae adhesinType 1 fimbriae adhesinUropathogenic Escherichia coli adhesinsFimbrial lectinsPapGFimH
02

Mechanism of action

Cranberry proanthocyanidins (PACs) inhibit bacterial adhesion by binding to fimbrial adhesins (e.g., PapG and FimH) on the surface of uropathogenic bacteria, preventing their attachment to host uroepithelial receptors through competitive inhibition and steric hindrance.

03

Biological functions

Bacterial adhesionHost cell colonizationBiofilm formation
04

Disease associations

Urinary tract infectionCystitisPyelonephritis
05

Safety considerations

Potential interaction with warfarinRisk of kidney stones due to high oxalate content in cranberry productsGastrointestinal upset at high doses
06

Interacting drugs

Cranberry proanthocyanidins

3 more in the full profile.

07

Biomarkers

Urinary anti-adhesion activity (AAA)Bacterial count in urine (CFU/mL)

Beyond the preview

Go deeper on Bacterial adhesins (PapG and FimH) (PapG/FimH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial adhesins (PapG and FimH) (PapG/FimH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call